1.
Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on gl...
by Zieve, Franklin J., MD, PhD
Clinical therapeutics, 2007, Vol.29 (1), p.74-83
2.
Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Typ...
by Schwartz, Sherwyn L.
Diabetes technology & therapeutics, 2011-12-01, Vol.13 (12), p.1219-1227
3.
Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: A randomized, double-blind, two-arm, parallel-group, placebo-controlled...
by Schwartz, Sherwyn L., MD
Clinical therapeutics, 2008, Vol.30 (5), p.858-867
4.
Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in...
by Schwartz, Sherwyn L., MD
Clinical therapeutics, 2008, Vol.30 (6), p.1081-1088
5.
The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study
by Schwartz, Sherwyn L
Metabolic syndrome and related disorders, 2010-04, Vol.8 (2), p.179-188
6.
Insulin pharmacokinetics following dosing with Technosphere insulin in subjects with chronic obstructive pulmonary disease
by Potocka, Elizabeth
Current medical research and opinion, 2010-10, Vol.26 (10), p.2347-2353
7.
Humalog® KwikPen™: an insulin-injecting pen designed for ease of use
by Schwartz, Sherwyn L
Expert review of medical devices, 2010-11-01, Vol.7 (6), p.735-743
8.
Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: A 29-day, multicenter, open-Label, dose-escalation study
by Thisted, Ronald A
Clinical therapeutics, 2006, Vol.28 (10), p.1607-1618
9.
Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-bl...
by Lewin, Andrew, MD
Clinical therapeutics, 2007, Vol.29 (5), p.844-855
10.
A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50...
by Schwartz, Sherwyn
Clinical therapeutics, 2006, Vol.28 (10), p.1649-1657
11.
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
by Drucker, Daniel J, Dr
The Lancet (British edition), 2008, Vol.372 (9645), p.1240-1250
12.
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
by Schwartz, Sherwyn
Current medical research and opinion, 2011-01, Vol.27 (1), p.151-162
13.
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
by Bergenstal, Richard M, Dr
The Lancet (British edition), 2010, Vol.376 (9739), p.431-439
14.
The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study
by Fischer, Jerome S
Current medical research and opinion, 2004-11, Vol.20 (11), p.1703-1710
15.
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
by Bays, Harold E
The journal of clinical endocrinology and metabolism, 2011-09, Vol.96 (9), p.2889-2897
16.
A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetes
by Feldman, Ben
Diabetes technology & therapeutics, 2003, Vol.5 (5), p.769-779
17.
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
by Ehrmann, David A
The journal of clinical endocrinology and metabolism, 2006-01, Vol.91 (1), p.48-53
18.
The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes
by Mastrototaro, John
Diabetes technology & therapeutics, 2008-10-01, Vol.10 (5), p.385-390
19.
Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system
by Bode, Bruce
Diabetes technology & therapeutics, 2004-04, Vol.6 (2), p.105-113
20.
Validation of the SoloSTAR Insulin Pen
by Schwartz, Sherwyn
Diabetes technology & therapeutics, 2008-10-01, Vol.10 (5), p.351-357
